M.d. Anderson Cancer Center

This pilot study tests whether infliximab can safely reverse insulin dependence in people who developed diabetes after checkpoint inhibitor cancer treatment. About 14 participants will receive the drug and be monitored for side effects and blood sugar control. The goal is to see …

This early-phase study tests whether adding a new drug called SAR445877 to standard chemotherapy (FOLFOX6) and a targeted therapy (bevacizumab) is safe for people with a specific type of advanced colorectal cancer that hasn't spread yet. About 41 adults with microsatellite stable…

This early-phase trial tests two drugs, olutasidenib and ziftomenib, in adults with a certain type of acute myeloid leukemia (AML) that has returned or not responded to treatment. The study first finds a safe dose, then checks if the combination helps control the cancer. About 20…

This study tests an oral form of cladribine combined with two other drugs (low-dose cytarabine and venetoclax) in people with acute myeloid leukemia (AML). The first part finds the safest dose; the second part checks if that dose helps control the disease. About 58 adults with re…

This early study tests whether taking a blood sample directly from veins inside the brain is safe and can provide the same detailed information about high-grade glioma as a traditional surgical biopsy. Twenty adults with suspected or confirmed high-grade glioma will participate. …

This study looks at whether recording your doctor visit helps you remember what was said and share it with family or caregivers who weren't there. About 200 adults with advanced cancer will be asked to record their clinic visit. A week later, they'll answer questions about how us…